<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163076">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01845896</url>
  </required_header>
  <id_info>
    <org_study_id>13.20/reva13.02</org_study_id>
    <nct_id>NCT01845896</nct_id>
  </id_info>
  <brief_title>Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis</brief_title>
  <official_title>Rehabilitation in MS: Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bert Op't Eijnde</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hasselt University</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effects of a combined training programme and
      a high intensity interval training programme on insulin resistance, muscle strength/ muscle
      contractile properties, aerobic capacity and body composition in MS patients.

      It is assumed that the the above mentioned clinical parameters will improve due to physical
      exercise.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>insulin sensitivity (insulin profile)</measure>
    <time_frame>change from baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>glucose and insulin concentration measurements in blood</description>
  </primary_outcome>
  <primary_outcome>
    <measure>muscle contractile properties</measure>
    <time_frame>from baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>measurements of cross sectional area and fiber distribution in muscle fibers of the m. vastus lateralis + measurements of enzymatic reactions, ATP, glycogen, ...</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>muscle strength of knee extensor/flexor</measure>
    <time_frame>change from baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>by means of an isokinetic dynamometer the muscle strength and endurance will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aerobic capacity</measure>
    <time_frame>change from baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>by means of a submaximal endurance test (ergometer)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cytokine profile</measure>
    <time_frame>change from baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>measurements of blood cytokine levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported measures</measure>
    <time_frame>Change from baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The self-reported measures contains some questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>Change from baseline to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Weight, body fat% and lean tissue% will be assessed by means of a DEXA scan</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Multiple Sclerosis</condition>
  <condition>Healthy Controls</condition>
  <arm_group>
    <arm_group_label>Combined exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 weeks combined exercise programme (supervised)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High intensity interval training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 weeks high intensity interval exercise programme (supervised)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>sedentary/habitual lifestyle</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Training</intervention_name>
    <arm_group_label>Combined exercise</arm_group_label>
    <arm_group_label>High intensity interval training</arm_group_label>
    <other_name>12 weeks of high intensity interval training or combined exercise</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed MS according to the McDonald criteria

          -  Expanded Disability Status Scale (EDSS) between 0.5 and 6

          -  Be able to train 5 times in 2 weeks at the University

        Exclusion Criteria:

          -  Comorbidities like cardiovascular-, respiratory-, orthopaedic or metabolic diseases
             (like diabetes type 2)

          -  Having had an relapse in a period of 3 months prior to the start of the intervention
             period

          -  Having an relapse during the intervention period

          -  Pregnancy and other contra indications for physical activity

          -  Mental disorders
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Inez Wens, M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Reval/Biomed, Hasselt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bert Opt Eijnde, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Reval/Biomed, Hasselt University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Reval</name>
      <address>
        <city>Diepenbeek</city>
        <zip>3590</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 3, 2014</lastchanged_date>
  <firstreceived_date>April 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hasselt University</investigator_affiliation>
    <investigator_full_name>Bert Op't Eijnde</investigator_full_name>
    <investigator_title>Ph.D</investigator_title>
  </responsible_party>
  <keyword>high intensity interval training</keyword>
  <keyword>combined training</keyword>
  <keyword>insulin resistance</keyword>
  <keyword>muscle contractile properties</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
